Literature DB >> 12622518

Historical technical developments in mammography.

Arthur G Haus1.   

Abstract

In mammography it is most important to consistently produce high-contrast, high resolution images at the lowest radiation dose consistently with high image quality. Today it is possible to obtain mammograms with higher image quality that require significantly lower radiation dose compared to mammograms dating back to the 1970's and early 1980's. Some of the technical developments due to x-ray equipment and image receptors and quality control programs that have let to todays high quality mammographic images are discussed in this article.

Mesh:

Year:  2002        PMID: 12622518     DOI: 10.1177/153303460200100204

Source DB:  PubMed          Journal:  Technol Cancer Res Treat        ISSN: 1533-0338


  4 in total

Review 1.  Cancer risks associated with external radiation from diagnostic imaging procedures.

Authors:  Martha S Linet; Thomas L Slovis; Donald L Miller; Ruth Kleinerman; Choonsik Lee; Preetha Rajaraman; Amy Berrington de Gonzalez
Journal:  CA Cancer J Clin       Date:  2012-02-03       Impact factor: 508.702

Review 2.  Reconstruction of absorbed doses to fibroglandular tissue of the breast of women undergoing mammography (1960 to the present).

Authors:  Isabelle Thierry-Chef; Steven L Simon; Robert M Weinstock; Deukwoo Kwon; Martha S Linet
Journal:  Radiat Res       Date:  2011-10-12       Impact factor: 2.841

3.  Comparison of 1- and 2-year screening intervals for women undergoing screening mammography.

Authors:  E S Wai; Y D'yachkova; I A Olivotto; S Tyldesley; N Phillips; L J Warren; A J Coldman
Journal:  Br J Cancer       Date:  2005-03-14       Impact factor: 7.640

4.  Breast fibroadenomas are not associated with increased breast cancer risk in an African American contemporary cohort of women with benign breast disease.

Authors:  Asra N Shaik; Julie J Ruterbusch; Eman Abdulfatah; Resha Shrestha; M H D Fayez Daaboul; Visakha Pardeshi; Daniel W Visscher; Sudeshna Bandyopadhyay; Rouba Ali-Fehmi; Michele L Cote
Journal:  Breast Cancer Res       Date:  2018-08-09       Impact factor: 6.466

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.